What is the share price of DABUR in 2026?
The share price of Dabur India Limited (traded on the National Stock Exchange of India under the ticker DABUR) is approximately 424.20 INR. Dabur is a leading multinational fast-moving consumer goods (FMCG) company specializing in Ayurvedic medicines, personal care products, and natural food items. Its stock performance throughout 2026 reflects rural and urban consumer demand trends in India, raw material agricultural input costs, competitive pressures within the herbal and consumer products market, quarterly volume growth figures, and broader macroeconomic sentiment impacting Indian consumer staples.
Related FAQs
Whether Dabur is a good stock to buy depends on your investment horizon and risk tolerance. With a base case target of Rs 486.2 for 2026 and long-term potential reaching Rs 591.
Dabur India Limited consensus stock predictions among fast-moving consumer goods analysts reflect a constructive growth outlook, supported by strong brand equity in Ayurvedic and natural healthcare products, expanding rural and urban retail distribut...
No, Dabur India is not debt-free. As of March 2026, the company's current portion of total debt was 10.902 billion. While the company has actively managed its liabilities over the past five years—with debt levels fluctuating between a low of 4.
Yes, Dabur is a profitable company. For the fourth quarter of the 2025-26 fiscal year, Dabur India reported a consolidated net profit of Rs 362 Crore, which was a 16% increase from Rs 312.7 Crore in the previous year.
The future outlook for Dabur India share prices is supported by its strong brand equity in the fast-moving consumer goods sector, leadership in Ayurvedic health products, and expansive rural and urban distribution networks.
Dabur products are used for health, personal care, and wellness. The company manufactures a variety of Ayurvedic healthcare products and fast-moving consumer goods (FMCG), including hair care, oral care, and food items.
The iconic global consumer goods and Ayurveda brand name Dabur has a fascinating linguistic origin rooted in late 19th-century India.
Dabur India Limited boasts a rich corporate history spanning over a century and a half, having been originally established in the year 1884 by Dr. S.K. Burman in the-then Calcutta.
Mohit Malhotra, serving as the Chief Executive Officer of Dabur India, receives an annual remuneration package totaling approximately 15.35 crore Indian rupees.
Dabur is widely recognized as one of the world's leaders in Ayurveda and natural healthcare products, offering a portfolio of over 250 herbal and natural consumer goods.
Dabur India Limited is a renowned multinational consumer goods company celebrated for its authentic Ayurvedic and natural healthcare products.
Dabur India Ltd. is a renowned multinational consumer goods company specializing in ayurvedic, natural healthcare, and personal care products.
Dabur, a major Indian multinational consumer goods company, has periodically encountered public and regulatory scrutiny regarding product ingredient labeling, quality standards testing for packaged juices and ayurvedic formulations, comparative adver...
Dabur maintains a documented commitment to ethical conduct through its Code of Conduct, which applies to all directors and employees.
Dr Lal PathLabs provides diagnostic and healthcare testing services internationally across 23 countries, operating through an extensive network that includes more than 150 partner hospitals and reference laboratories.
The long-term outlook for Dabur India suggests potential growth, with analysts projecting a target of Rs 591.8 by fiscal year 2028, contingent on sustained earnings growth and potential sector multiple re-ratings.
Dabur India inaugurated a state-of-the-art fast-moving consumer goods manufacturing facility located in Tindivanam, Tamil Nadu.
Enel's primary regional headquarters in the United States, operating as Enel North America, is located in Andover, Massachusetts.